CAS: 1233322-09-2
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | BI-69A11 REF: TM-T25150CAS: 1233322-09-2 | 96.97% | 46,00 €~369,00 € | Mar 11 Mar 25 |
 | (E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one REF: 3D-IZB32209CAS: 1233322-09-2 | Min. 95% | - - - | Producto descatalogado |
BI-69A11
CAS:1233322-09-2
BI-69A11 is a dual AKT/NFkB inhibitor, increasing colon cancer cell sensitivity to mda-7/IL-24.
Fórmula:
C25H16ClN3O2
Pureza:
96.97%
Forma y color:
Solid
Peso molecular:
425.87
Ref: TM-T25150
| 1mg | 46,00 € | ||
| 2mg | 57,00 € | ||
| 5mg | 82,00 € | ||
| 10mg | 96,00 € | ||
| 25mg | 180,00 € | ||
| 50mg | 259,00 € | ||
| 100mg | 369,00 € | ||
| 1mL*10mM (DMSO) | 93,00 € |
Entrega estimada en Estados Unidos, el Martes 11 de Marzo de 2025
![(E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one](https://static.cymitquimica.com/products/3D/thumb/IZB32209.jpg)
(E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one
CAS:1233322-09-2
(E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one is a novel anticancer drug that is currently undergoing clinical trials. It has been …
Fórmula:
C25H16ClN3O2
Pureza:
Min. 95%
Peso molecular:
425.9 g/mol
Ref: 3D-IZB32209
| 5mg | Descatalogado | Solicitar información | |
| 10mg | Descatalogado | Solicitar información | |
| 25mg | Descatalogado | Solicitar información | |
| 50mg | Descatalogado | Solicitar información | |
| 100mg | Descatalogado | Solicitar información |
